Board of directors appoints president and CEO.PITTSBURGH--(HealthWire)--Sept. 24, 1996--Biological Detection, Inc. (BDI BDI Burundi (ISO Country code) BDI Beck Depression Inventory BDI Belief-Desire-Intention (AI agents) BDI Baltic Dry Index BDI Basic Driver Improvement (traffic school) ) announced today the appointment of Dr. D. Lansing Taylor as President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . Dr. Taylor has been the Director of the National Science Foundation, Center for Light Microscope Noun 1. light microscope - microscope consisting of an optical instrument that magnifies the image of an object binocular microscope - a light microscope adapted to the use of both eyes Imaging and Biotechnology, as well as the Vice-Dean for Molecular Sciences at Carnegie Mellon University Carnegie Mellon University, at Pittsburgh, Pa.; est. 1967 through the merger of the Carnegie Institute of Technology (founded 1900, opened 1905) and the Mellon Institute of Industrial Research (founded 1913). . Dr. Taylor was previously on the faculty of Harvard University Harvard University, mainly at Cambridge, Mass., including Harvard College, the oldest American college. Harvard College Harvard College, originally for men, was founded in 1636 with a grant from the General Court of the Massachusetts Bay Colony. where he pioneered the development of cell screening tools, including ratio-imaging and fluorescent analogs of proteins used as biosensors. Dr. Taylor was also a founder and scientific advisor of Biological Detection Systems, Inc., which was purchased by Amersham International, plc last year. "He will play a critical role in defining new business opportunities as we pursue the high precision and high through-put drug discovery market using multi-color, fluorescence-based screens of cells. We are very fortunate to have attracted him," said John M. Boles, Chairman of BDI. BDI is focusing on commercializing high precision, and high throughput screening tools that use cells and a variety of fluorescence-based reagents, together with robotics, fluidics fluidics, branch of engineering and technology concerned with the development of equivalents of various electronic circuits using movements of fluid rather than movements of electric charge. , optical instrumentation and bioinformatics to accelerate the drug discovery process. The company is creating commercial and R&D partnerships that will help make Biological Detection, Inc. the leader in cell-based, high precision and high throughput screening. CONTACT: Biological Detection, Inc. D. Lansing Taylor, Ph.D., 412/826-3857 |
|
||||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion